Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-936-4000
Dr. Junck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Larry Junck is a neurologist and neuro-oncologist at the University of Michigan in Ann Arbor. He has active certification in both specialties. He completed his medical education at University of Michigan, followed by internship and residency at Stanford and fellowship at Memorial Sloan-Kettering Cancer Center in New York. For many years he served as director of the Brain Tumor Program at University of Michigan. Awards include Outstanding Clinician Award from University of MIchigan, Teaching Award from the American Academy of Neurology, and recognition by Best Doctors and Castle-Connolly Top Doctors. He serves on the Board of Directors of Michigan State Medical Society. Additionally, he has expertise in the neurological complications of climate change and air pollution and has spoken and published on these topics. He is the co-founder of Neurologists Interested in Climate and Health (NICHe), the founder of Michigan Medicine Climate Voices (MMCV), and member of the Board of Directors of Michigan Clinicians for Climate Action.
Education & Training
Memorial Sloan-Kettering Cancer CenterNA, Positron Emission Tomography, 1981 - 1983
Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1977 - 1980- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1976 - 1977
University of Michigan Medical SchoolClass of 1976
Certifications & Licensure
MI State Medical License 1983 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Publications & Presentations
PubMed
- CRE25-043: Treatment of HER2-Positive Breast Cancer With Leptomeningeal Metastases With Intrathecal Trastuzumab.Vasu Munjapara, John Rice, Lindsay Robell, Kelsey Peters, Denise Leung
Journal of the National Comprehensive Cancer Network. 2025-03-28 - Neurology and climate change.Larry Junck, Ali Saad, Bret Andrews
The Lancet. Neurology. 2024-06-01 - 12 citationsMetabolomic Profiles of Human Glioma Inform Patient Survival.Andrew J Scott, Luis O Correa, Donna M Edwards, Yilun Sun, Visweswaran Ravikumar
Antioxidants & Redox Signaling. 2023-11-01
Grant Support
- ZD1839 For Recurrent/ Progressive Malig Astrocytoma, Glioblastoma, &MeningiomaNational Center For Research Resources2004
- Phase I/II Trial Of CCI-779 (Nsc# 683864) In Patients W/ Malignant GliomaNational Center For Research Resources2004
- Phase I/II Trial Cpt-11&Temozolomide(Temodar)In Pts.W/Malignant Glioma Umcc 0048National Center For Research Resources2004
- Phase II Study Of Su101 For Patients With Anaplastic ASTNational Center For Research Resources2000–2002
- Su101 Versus Procarbazine For First Relapse Patients W/ GlioblastomaNational Center For Research Resources1999–2002
Committees
- Leader, Michigan Medicine Climate Voices 2024 - Present
- Co-leader, Neurologists Interested in Climate and Health 2023 - Present
- Member, Board of Directors, Michigan Clinicians for Climate Action 2022 - Present
- Member, Editorial Board, Neurology 2016 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
